Content Warning / Educational Disclaimer: This article post contains sensitive topics and reflects Open College UK Limited’s opinions for informational purposes only.

Introduction to Gene Therapy

The concept of gene therapy arose during the mid-1900s when researchers looked for ways to remedy genetic errors through the direct manipulation of human genes. During the next twenty years, researchers explored the scientific foundations and practical possibilities of that approach.

In that first stage, companies and scientists grappled with the questions of whether that manipulation could be carried out, and if so, what form it might take and which diseases it might address.

Once those first demonstrations of feasibility were in hand, some of those researchers moved on to the next phase of exploration, asking whether the new approach could be safe and effective in humans. That period of question and answer played out during the 1980s, with gene therapy moving beyond proof-of-concept studies early in the 1990s. That ‘go’ order led to a rush of innovation and creativity in which researchers tested gene therapy’s potential worldwide.

Their efforts produced encouraging results. In case after case, proof-of-principle laboratory studies were followed by pre-clinical evaluations, followed by the generation of human-grade treatment, followed by Phase I and II clinical studies and, in some cases, to plans for pivotal trials.

Encouraging results even led to regulatory and commercial activities. As for the former, in 2003 the US Food and Drug Administration approved the first gene therapy product, consisting of ex vivo transduced autologous T cells that express a tumour-specific chimeric antigen receptor. Indeed, in some of those inventions, gene therapy found a neat and effective role. But as of 2020, the practical legacy of thirty years’ worth of scientific discovery had yet to be felt. Only a single gene therapy product had reached the market in Europe. In 2012, the European Medicines Agency conditionally approved the first gene therapy product for the treatment of transplanted-associated retinopathies.

Definition and Basics

Gene therapy is designed to introduce genetic material into patients’ cells to compensate for abnormal genes or to make a beneficial protein.

For example, the mutated gene may direct the cell to make a protein that causes cancer. The normal copy of the gene would direct the production of a protein that does not drive the abnormal cell growth associated with cancer.

Alternatively, the therapeutic genes delivered to target cells may enable those cells to destroy cancer cells in the local environment of a tumour. Most gene therapy studies are aimed at one of two broad groups of diseases. Somatic gene therapy adds genes to body cells by direct injection or other means, while germline gene therapy adds genes to germ cells, the sperm or eggs.

Gene therapy may be classified into two types: somatic cell gene therapy, which results in changes in body cells, such as cells of the liver, lung, or bone marrow. Any changes made to the DNA in these body cells are passed on to any offspring in these cells if the patient is a reproductive cell line.

Therefore, inheritable changes as a result of somatic cell gene therapy offered as a therapy treatment are unlikely. If permitted, the altered DNA of the treated cells could be obtained from cells in a father or mother’s body and impregnate a surrogate mother, an unrelated woman who would carry and deliver the infant. Germline gene therapy results in changes in the sperm, eggs, or any of the cells that give rise to sperm and eggs. All bodily cells would derive from germ cells, including reproductive cells.

History Background

In ancient Greece, the hereditary passing of features from one generation to the next was established.

It has been learned that genes are produced chemically, proteins are a well-known feature, and the function of others in the cell is to maintain their basic structure and role.

DNA is called a double helix of life. These DNA strands wind around the proteins called histones; the histones become ionized by the amino acids in their structure. Thus, the ions in other known materials gather around and participate in the composition of a new generation of cells.

Types of Gene Therapy

Exogenous DNA, either in the form of a gene or as a nucleic acid vaccine, represents a natural choice as a means of augmenting or replacing the biological molecule that is absent or malfunctioning in the patient. Types of gene therapy, and one potential hypothesis for the poor performance, are discussed. It is still too early to say what will demonstrate the clinical potential of gene therapy, to either treat inborn errors or transfer immunity.

The delivery of mutated genes that are replaced with the correct version, and the introduction of foreign genes to produce a desired therapeutic effect, are called gene therapy.

They plan to use these artificial genes to try to cure certain genetic diseases. The limiting factor to the more widespread use of gene therapy is being able to introduce foreign genes and then get these genes to function in the desired way. There are different vectors to carry these genes to their desired location.

Disclaimer
The content on this website, including all articles, posts, and comments, is provided by Open College UK Limited for educational and informational purposes only. It reflects the views, experiences, and opinions of Open College UK Limited at the time of writing. Nothing on this site constitutes professional advice—medical, psychological, legal, or otherwise.

Always consult a licensed professional (such as a GP, medical doctor, psychologist, or therapist) before making any decisions that could affect your health, well-being, or legal obligations.

The views expressed here are those of Open College UK Limited and are opinion-based. They are not intended to accuse, defame, or target any individual, group, business, organisation, or entity. Any resemblance to real persons, organisations, or events is purely coincidental.

Use of this website and any reliance on its content is entirely at your own risk. Open College UK Limited does not accept responsibility or liability for any consequences, direct or indirect, resulting from actions taken based on this content.

This website may discuss sensitive, controversial, or challenging topics intended to inform, provoke thought, and raise awareness, not to incite or offend. Readers are responsible for interpreting and applying the content responsibly and legally in their own context.

Accuracy and completeness: All information in this article, post, or any other content on this website may not be accurate, complete, or up to date at the time of reading. Readers must undertake their own research and exercise independent judgment before acting upon any information contained herein.

Copyright: All content on this website is owned by Open College UK Limited. Reproduction, distribution, or use without prior written consent is prohibited.

Please feel free to link to this post.